Barrett's Esophagus Clinical Trials

A listing of Barrett's Esophagus medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1376 clinical trials
Lung Surgery With Enhanced Recovery VS. Lung Surgery Without Enhanced Recovery

Methods: A Randomized Controlled Trial was designed to collect the perioperative data on consecutive patients undergoing lung resection for primary lung cancer. Patients will be randomizely assigned to the ERAS- Group and Control- Group. Short-term and long- term effect will be compared between the two groups.

cancer
enhanced recovery after surgery
lung surgery
lung operation
pulmonary resection
  • 18 views
  • 19 Feb, 2024
  • 1 location
Effectiveness and Acceptability of MINDFULNESS by Smartphone for Patients With Chronic Migraine and Medication Overuse

This modality will allow the patients to continue their therapeutic process and to be followed regularly during the one year after withdrawal

therapeutic process
migraine
analgesia
chronic migraine
  • 0 views
  • 19 Feb, 2024
  • 1 location
PTI-125 100 mg for Mild-to-moderate Alzheimer's Disease Patients

An Open-label study for patients who completed the previous studies, PTI-125-02 or PTI-125-03. Additional new patients will be included for a total of 100 patients enrolled for this study.

amyloid
galantamine
dementia
alzheimer's disease
mini-mental state examination
  • 0 views
  • 19 Feb, 2024
  • 9 locations
Accelerometer Sensing for Micra AV Study

The purpose of the AccelAV Study is to characterize chronic AV synchrony in subjects implanted with MicraTM AV device. This study will be conducted upon market approval of the MicraTM AV Transcatheter Pacing System.

atrioventricular block
  • 0 views
  • 19 Feb, 2024
  • 6 locations
A Multicentre Non-Blinded Study Exploring Self-Administration of Chemotherapy in the Home Environment

This study is to see if the standard of care subcutaneous injection of bortezomib can safely be administered at home by the patient or caregiver. All tests and assessments are based on standard of care procedures.

cancer
multiple myeloma
bortezomib
  • 0 views
  • 24 Nov, 2025
  • 1 location
Mobile App as a Guide to Exercises for Patients With Chronic Stroke

Even if chronicity leads us to think about the stabilization of the physical condition, It is thought that the best results will be found among the subjects who will use the App.

hemiparesis
hemiplegia
hemiplegia or hemiparesis
physical rehabilitation
stroke
  • 0 views
  • 19 Feb, 2024
  • 1 location
A Study to Look at How Safe NNC0472-0147 is in Healthy People and in People With Type 2 Diabetes

Participants will get once daily injections of either NNC0472-0147 or insulin glargine for a treatment period of fourteen days. The injections will be given under the skin (subcutaneously, s.c.) of the left thigh. Participants will be in the study for about 7 weeks. There will be 15 visits with the …

cholesterol level
low density lipoprotein
type 2 diabetes mellitus
type 1 diabetes mellitus
oophorectomy
  • 0 views
  • 19 Feb, 2024
  • 2 locations
Helping Families Pilot of a Family Resilience Program for Families Experiencing Homelessness and Parental Substance Use

Our primary hypothesis is that the adapted family resilience program will be feasible and acceptable to families with a recent history of homelessness and parental substance use disorder. Families that are eligible to participate in the study will be assigned randomly to one of two groups, 1) adapted family resilience …

  • 0 views
  • 19 Feb, 2024
  • 1 location
Test Food4GutMarKIT - Evaluation of a Tailored Personalized Food Concept for a Healthy Gut Microbiota and Validation of Biomarkers for Monitoring of Its Effects  

The study will be running over 18 weeks (including a 6-week wash-out period) and it will include 9 visits at the clinic.

Accepts healthy volunteers
  • 0 views
  • 19 Feb, 2024
  • 3 locations
A Study of SY 5609 a Selective CDK7 Inhibitor in Advanced Solid Tumors

This is a dose escalation study and will be the first to administer SY-5609 alone to humans with select advanced solid tumors and in combination with Fulvestrant to patients with HR positive, HER2-negative breast cancer.

alopecia
measurable disease
human chorionic gonadotropin
health screening
gonadotropin
  • 0 views
  • 19 Feb, 2024
  • 5 locations